sounds to me like they are trying to effect ribonuclease activity in the translation/transcription processes. This method would rely on mutagen nucleic acid sequences to be lethal genes to be effective.
it may be effective in stopping cancers, but my thought is this would only effect some cancers and not be a panacea.
translation: I think this stock has limited upside potential unless it has other drugs in the pipeline
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.